Institute for Research in Immunology and Cancer has secured funding from CECR, the same government agency that supported its launch ten years ago.

Apeel has taken its total funding to $110m after raising $70m in a series C round led by Viking Global Investors.

Multi-million-dollar investments by Anges will help Vasomune progress its peptide-based therapy for blood vessel-related diseases to the clinic.

Real estate electricity trading platform Blueprint Power has been backed by Congruent Ventures, whose limited partners include University of California.

ETH Zurich spinout Rapyuta Robotics has signed up investors including Sony Innovation Fund for a $9.5m cash injection, two years after raising $10m from SBI Investments.

The computer vision technology spinout from ETH Zurich has secured $30m in a GV-led round that included NGP Capital, bringing its total funding to $43m.